Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
February 10, 2022	SC 13G/A	An amendment to the SC 13G filing	0000093751-22-000122.pdf 0000093751-22-000122.rtf View HTML
February 9, 2022	SC 13G/A	An amendment to the SC 13G filing	0001104659-22-016399.pdf 0001104659-22-016399.rtf View HTML
February 7, 2022	SC 13G/A	An amendment to the SC 13G filing	0000834237-22-007946.pdf 0000834237-22-007946.rtf View HTML
January 28, 2022	S-8	Securities offered to employees pursuant to employee benefit plans	0001193125-22-021580.pdf 0001193125-22-021580.rtf 0001193125-22-021580.xls View HTML
January 24, 2022	8-K	Report of unscheduled material events or corporate event	0001193125-22-016101.pdf 0001193125-22-016101.rtf 0001193125-22-016101.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
January 5, 2022	4	Statement of changes in beneficial ownership of securities	0001562180-22-000236.pdf 0001562180-22-000236.rtf 0001562180-22-000236.xls View HTML
December 30, 2021	CT ORDER	CT ORDER	9999999997-21-006044.pdf View HTML
December 15, 2021	8-K/A	Amendment to a previously filed 8-K	0001193125-21-358055.pdf 0001193125-21-358055.rtf 0001193125-21-358055.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
November 4, 2021	8-K	Report of unscheduled material events or corporate event	0001193125-21-319374.pdf 0001193125-21-319374.rtf 0001193125-21-319374.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
November 4, 2021	10-Q	Quarterly report which provides a continuing view of a company's financial position	0001628280-21-021760.pdf 0001628280-21-021760.rtf 0001628280-21-021760.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax